Clinical Trial

Ultra-high-caloric, Fatty Diet in ALS

Study acronym: LIPCAL-ALS II
Recruiting
View on ClinicalTrials.gov →
Summary
This study aims at evaluating efficacy and tolerability of an ultra-high-caloric, fatty diet (UFD) compared to placebo in patients with amyotrophic lateral sclerosis (ALS).
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2024-02-19; most recent amendment 2026-04-30.
Status change: Not Yet Recruiting → Recruiting 2024-12-03
Trial Details
NCT Number NCT06280079
Lead Sponsor University of Ulm
Conditions Amyotrophic Lateral Sclerosis
Enrollment 392 participants
Start Date 2024-06-01
Primary Completion 2028-01-01 (estimated)
Study Completion 2028-01-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-01